Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 79
Filter
2.
J Nephrol ; 35(5): 1437-1447, 2022 06.
Article in English | MEDLINE | ID: mdl-35119686

ABSTRACT

INTRODUCTION: Chikungunya virus was detected in cases of acute chikungunya fever in renal tissue. However, chikungunya virus-related kidney injury still lacks characterization, and it is unknown whether the kidneys are reservoirs for the virus. We sought to detect histopathological changes and viral antigens in renal tissue, and to evaluate kidney injury markers in different phases of chikungunya fever. METHODS: Two groups were evaluated in this exploratory study: patients with biopsy-proven kidney injury established after chikungunya fever, and patients with post-chikungunya fever chronic joint manifestations without known kidney injury, in whom we actively searched for kidney injury markers. RESULTS: In the first group, 15 patients had kidney injury 0.5-24 months after chikungunya fever. The most frequent histopathological diagnoses were glomerular lesions. No viral antigens were detected in renal tissue. High-risk genotypes were detected in patients with atypical hemolytic uremic syndrome and focal and segmental glomerulosclerosis. In the second group, 114 patients had post-chikungunya fever joint manifestations on average for 35.6 months. Mean creatinine and proteinuria were 0.9 mg/dl and 71.5 mg/day, respectively. One patient had isolated hematuria. There was no indication for renal biopsy in this group. CONCLUSIONS: Several histopathological features were found after chikungunya fever, without virus detection in renal tissue. These findings suggest that chikungunya virus may trigger kidney lesions with varying degrees of severity at different stages of infection. However, the probability that this virus replicates in the renal tissue seems unlikely.


Subject(s)
Chikungunya Fever , Chikungunya virus , Glomerulosclerosis, Focal Segmental , Kidney Diseases , Chikungunya Fever/complications , Chikungunya Fever/diagnosis , Chikungunya virus/genetics , Glomerulosclerosis, Focal Segmental/pathology , Humans , Kidney Diseases/diagnosis , Kidney Diseases/etiology , Kidney Diseases/pathology , Kidney Glomerulus/pathology
3.
Future Microbiol ; 16: 1371-1379, 2021 12.
Article in English | MEDLINE | ID: mdl-34812048

ABSTRACT

Aim: Cases of sporotrichosis are emerging in several states of Brazil, especially in the southeast. Recently, sporotrichosis has been reported in the state of Pernambuco in the northeastern region. The goal of this study was to shed new light on sporotrichosis in terms of the geographic distribution of human cases and provide an overview of sporotrichosis associated with zoonotic transmission. Patients & methods: From March 2017 to November 2019, 179 patients were diagnosed with sporotrichosis. Georeferencing analysis, spatial distribution and epidemiological features of all cases are described. Results: The data show the dynamics of accelerated transmission of sporotrichosis across urban and coastal areas of the state of Pernambuco. Conclusion: There is a need to decentralize health services and implement a One Health approach to this emerging disease.


Subject(s)
Sporothrix , Sporotrichosis , Brazil/epidemiology , Humans , Sporotrichosis/epidemiology
4.
Rev Soc Bras Med Trop ; 54: e0855, 2021.
Article in English | MEDLINE | ID: mdl-33886823

ABSTRACT

The persistence of serum-specific anti-chikungunya IgM antibodies (CHIKV-IgM) can vary after chikungunya fever (CHIK) infection. However, the factors related to its production are not yet known. We described a case series drawn up from data collected from 57 patients between 12 and 36 months after the acute phase of CHIK infection in Northeastern Brazil. CHIKV-IgM was detectable in 7/57 (12.3%) patients after 28.3 months of infection. No frequency differences in chronic musculoskeletal manifestations and underlying conditions were detected between patients with or without CHIKV-IgM. CHIKV-IgM was detected for up to 35 months in Brazilian patients after CHIK infection.


Subject(s)
Chikungunya Fever , Chikungunya virus , Antibodies, Viral , Brazil , Chikungunya Fever/diagnosis , Humans , Immunoglobulin M
5.
Rev. Soc. Bras. Med. Trop ; 54: e08552021, 2021. tab
Article in English | LILACS | ID: biblio-1288089

ABSTRACT

Abstract The persistence of serum-specific anti-chikungunya IgM antibodies (CHIKV-IgM) can vary after chikungunya fever (CHIK) infection. However, the factors related to its production are not yet known. We described a case series drawn up from data collected from 57 patients between 12 and 36 months after the acute phase of CHIK infection in Northeastern Brazil. CHIKV-IgM was detectable in 7/57 (12.3%) patients after 28.3 months of infection. No frequency differences in chronic musculoskeletal manifestations and underlying conditions were detected between patients with or without CHIKV-IgM. CHIKV-IgM was detected for up to 35 months in Brazilian patients after CHIK infection.


Subject(s)
Humans , Chikungunya virus , Chikungunya Fever/diagnosis , Brazil , Immunoglobulin M , Antibodies, Viral
6.
PLoS One ; 15(12): e0242098, 2020.
Article in English | MEDLINE | ID: mdl-33270676

ABSTRACT

BACKGROUND: Tuberculosis screening in psoriasis patients is complex due to the immunological alterations associated with psoriasis, the presence of comorbidities, and the effect of immunosuppressive treatment. However, it is not established whether the results of screening tests are affected by these factors in psoriasis patients. OBJECTIVES: To determine whether there is a change in the results of the tuberculin skin test (TST) or the interferon-gamma release assay (IGRA) in psoriasis patients living in tuberculosis (TB)-endemic area after 12 weeks of methotrexate (MTX) treatment and to investigate the association of the test results with clinical and inflammatory markers. METHODS: Forty-five patients were selected for a prospective single-arm self-controlled study and followed for at least 18 months. The TST, IGRA, Psoriasis Area and Severity Index (PASI), and inflammatory factors (erythrocyte sedimentation rate (ESR), C-reactive protein, interferon-gamma (IFN-γ), and tumor necrosis factor-alpha levels), were determined before and after 12 weeks of oral 15 mg per week MTX administration and compared. The associations between the IGRA and TST results were verified before and after treatment according to inflammatory factors and clinical characteristics (age, blood glucose, weight, body mass index, disease duration, and PASI). RESULTS: We collected data on 25 patients who completed the full course of therapy and the follow-up. None of the patients developed TB. TST positivity was significantly elevated at week 12 (25% baseline vs 44% at week 12, P < 0.037). Three IGRAs followed the TST conversions. There was no difference between TST and IGRA pre- or posttreatment. Serum IFN-γ increased significantly in week 12 (15.95 pg/ml baseline vs 18.82 pg/ml at week 12, P < 0.005) and tended to be higher among TST-positive patients (P = 0.072). The baseline IGRA was associated with a higher ESR (P = 0.038). None of the test results were associated with clinical characteristics. CONCLUSIONS: In addition to the classic booster effect, TST conversions in patients using MTX can occur due to an increase in IFN-γ. However, it is not possible to exclude true TST conversions. Therefore, other diagnostic methods, like IGRA or chest tomography, should be used when the TST has intermediate results.


Subject(s)
Latent Tuberculosis/drug therapy , Methotrexate/administration & dosage , Psoriasis/drug therapy , Tuberculin Test/adverse effects , Adult , C-Reactive Protein/metabolism , Female , Humans , Immunosuppressive Agents/administration & dosage , Interferon-gamma/blood , Latent Tuberculosis/complications , Latent Tuberculosis/epidemiology , Latent Tuberculosis/microbiology , Male , Mass Screening , Methotrexate/adverse effects , Middle Aged , Psoriasis/blood , Psoriasis/complications , Psoriasis/epidemiology , Severity of Illness Index , Tumor Necrosis Factor-alpha/blood , Young Adult
8.
Medicine (Baltimore) ; 98(26): e16129, 2019 Jun.
Article in English | MEDLINE | ID: mdl-31261533

ABSTRACT

Individuals infected with human immunodeficiency virus (HIV) have higher morbidity and mortality due to cancer, which is the third most common cause of death in this group, despite the high effectiveness of antiretroviral therapy (ART). We describe the clinical and laboratory characteristics, initial staging and outcome of HIV-related lymphoma.We included 18 patients in the study, of whom 61.1% were male, mean age 41 years. Nine of the 18 patients (50%) had a diagnosis of HIV infection concurrent with the diagnosis of lymphoma.The most common histological types were diffuse non-Hodgkin B-cell lymphoma, 8 patients (44.4%); and Burkitt lymphoma, 5 (27.8%) cases. The Cotswold revision of the Ann Arbor staging classification in 14 patients (77.7%) was between III and IV. B Symptoms were present in 11 patients (61.1%), bulky mass was observed in 11 cases (61.1%) and had extra-nodal involvement in 8 patients (44.4%).Of the 18 cases analyzed, 8 followed on to second-line treatment, wherein the CODOX-M/IVAC scheme (cyclophosphamide, adriamycin, vincristine, methotrexate/ifosfamide, etoposide, and cytosine arabinoside) was used in 3 of the cases. The second most common scheme was etoposide, doxorubicin, vincristine and cyclophosphamide (EPOCH), used in 2 cases (25%), while in single cases (12.5% each) cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone (CHOEP), ifosfamide, etoposide, and carboplatin (ICE) and dexamethasone, cisplatin, and cytarabine (DHAP) were used.In this series, we observed very high mortality, equivalent to 44.4%, and a complete response in only 11.1%, much lower than that observed by other authors.We found that patients diagnosed with lymphoma associated with HIV had an advanced early clinical staging, and evolved with low response rates to chemotherapy.


Subject(s)
Lymphoma, AIDS-Related/epidemiology , Lymphoma, AIDS-Related/therapy , Adult , Antineoplastic Agents/therapeutic use , Burkitt Lymphoma/epidemiology , Burkitt Lymphoma/pathology , Burkitt Lymphoma/therapy , Female , Humans , Lymphoma, AIDS-Related/pathology , Lymphoma, Non-Hodgkin/epidemiology , Lymphoma, Non-Hodgkin/pathology , Lymphoma, Non-Hodgkin/therapy , Male , Neoplasm Staging , Retrospective Studies
9.
Rev Inst Med Trop Sao Paulo ; 57(4): 359-60, 2015.
Article in English | MEDLINE | ID: mdl-26422164

ABSTRACT

In this brief communication we describe the occurrence of a KPC-producing Serratia marcescens isolate in a home-care patient from Recife, Brazil. The blaKPC, blaSPM, blaIMP, blaVIM, blaOXA, blaCTX-M, blaSHV, blaTEM and blaGES genes were investigated by Polymerase Chain Reaction (PCR) and DNA sequencing. The isolate was positive for blaKPC-2 and blaTEM-1 and was resistant to aztreonam, cefepime, cefotaxime, imipenem, meropenem, gentamicin, ciprofloxacin and cefazidime, and susceptible only to amikacin, tigecycline and gatifloxacin. This is the first report in Brazil of KPC-producing S. marcescens clinical isolate outside of a hospital environment. Caregivers should be alert for the presence of this isolate in the community setting.


Subject(s)
Anti-Bacterial Agents/pharmacology , Serratia Infections/microbiology , Serratia marcescens/drug effects , Serratia marcescens/isolation & purification , beta-Lactamases/biosynthesis , Brazil , Electrophoresis, Gel, Pulsed-Field , Home Care Services , Humans , Male , Microbial Sensitivity Tests , Middle Aged , Serratia marcescens/enzymology
10.
Braz. j. infect. dis ; 19(1): 43-46, Jan-Feb/2015. tab
Article in English | LILACS | ID: lil-741231

ABSTRACT

Objective: This study was aimed to evaluate the prevalence of pertussis in adolescents and adults with cough lasting more than 14 days and less than 30 days. Methods: This is a prospective observational study in interepidemic period of pertusis. Ten public health outpatient clinics in the city of Recife, Brazil, were randomly selected for the study. The study population consisted of individuals aged 10 years and over with cough that had lasted between 14 and 30 days. Nasopharyngeal swabs were collected for culture and PCR in order to identify Bordetella pertussis. We adopted the Centers for Disease Control and Prevention in the US (CDC) definition of cases of pertussis. Results: A total of 192 individuals were identified as suspected cases. Their mean age was 40.7 years. Pertussis was confirmed in 10 of the 192 suspected cases, with an estimated prevalence of 5.21% (95% confidence interval 2.03-8.38). All cases met the clinical case definition for pertussis; one suspect had both culture and PCR positive. PCR confirmed 100% of the cases, 7/10 by PCR and 3/10 by epidemiological linkage with a case confirmed by PCR. Conclusion: During an interepidemic period, 1 in 20 cases of prolonged cough had pertussis, suggesting this is an important cause of prolonged cough in adolescents and adults. .


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Child , Female , Humans , Male , Middle Aged , Young Adult , Antibodies, Bacterial/blood , Bordetella pertussis , DNA, Bacterial/blood , Whooping Cough/epidemiology , Brazil , Bordetella pertussis/genetics , Bordetella pertussis/immunology , Prevalence , Prospective Studies , Whooping Cough/diagnosis
11.
Braz J Infect Dis ; 19(1): 43-6, 2015.
Article in English | MEDLINE | ID: mdl-25452019

ABSTRACT

OBJECTIVE: This study was aimed to evaluate the prevalence of pertussis in adolescents and adults with cough lasting more than 14 days and less than 30 days. METHODS: This is a prospective observational study in interepidemic period of pertusis. Ten public health outpatient clinics in the city of Recife, Brazil, were randomly selected for the study. The study population consisted of individuals aged 10 years and over with cough that had lasted between 14 and 30 days. Nasopharyngeal swabs were collected for culture and PCR in order to identify Bordetella pertussis. We adopted the Centers for Disease Control and Prevention in the US (CDC) definition of cases of pertussis. RESULTS: A total of 192 individuals were identified as suspected cases. Their mean age was 40.7 years. Pertussis was confirmed in 10 of the 192 suspected cases, with an estimated prevalence of 5.21% (95% confidence interval 2.03-8.38). All cases met the clinical case definition for pertussis; one suspect had both culture and PCR positive. PCR confirmed 100% of the cases, 7/10 by PCR and 3/10 by epidemiological linkage with a case confirmed by PCR. CONCLUSION: During an interepidemic period, 1 in 20 cases of prolonged cough had pertussis, suggesting this is an important cause of prolonged cough in adolescents and adults.


Subject(s)
Antibodies, Bacterial/blood , Bordetella pertussis , DNA, Bacterial/blood , Whooping Cough/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Bordetella pertussis/genetics , Bordetella pertussis/immunology , Brazil , Child , Female , Humans , Male , Middle Aged , Prevalence , Prospective Studies , Whooping Cough/diagnosis , Young Adult
12.
Mem Inst Oswaldo Cruz ; 109(7): 912-7, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25410995

ABSTRACT

After the World Health Organization officially declared the end of the first pandemic of the XXI century in August 2010, the influenza A(H1N1)pdm09 virus has been disseminated in the human population. In spite of its sustained circulation, very little on phylogenetic data or oseltamivir (OST) resistance is available for the virus in equatorial regions of South America. In order to shed more light on this topic, we analysed the haemagglutinin (HA) and neuraminidase (NA) genes of influenza A(H1N1)pdm09 positive samples collected during the pandemic period in the Pernambuco (PE), a northeastern Brazilian state. Complete HA sequences were compared and amino acid changes were related to clinical outcome. In addition, the H275Y substitution in NA, associated with OST resistance, was investigated by pyrosequencing. Samples from PE were grouped in phylogenetic clades 6 and 7, being clustered together with sequences from South and Southeast Brazil. The D222N/G HA gene mutation, associated with severity, was found in one deceased patient that was pregnant. Additionally, the HA mutation K308E, which appeared in Brazil in 2010 and was only detected worldwide the following year, was identified in samples from hospitalised cases. The resistance marker H275Y was not identified in samples tested. However, broader studies are needed to establish the real frequency of resistance in this Brazilian region.


Subject(s)
Hemagglutinins/genetics , Influenza A Virus, H1N1 Subtype/genetics , Influenza, Human/epidemiology , Neuraminidase/genetics , Pandemics , Antiviral Agents/therapeutic use , Biomarkers/analysis , Brazil/epidemiology , Drug Resistance, Viral/physiology , Female , Gene Frequency/genetics , Humans , Influenza A Virus, H1N1 Subtype/classification , Influenza A Virus, H1N1 Subtype/pathogenicity , Influenza, Human/virology , Mutation/genetics , Oseltamivir/therapeutic use , Phylogeny , Pregnancy , RNA, Viral/analysis , Sequence Analysis, DNA/methods , Virulence , Virulence Factors/genetics
13.
Mem. Inst. Oswaldo Cruz ; 109(7): 912-917, 11/2014. tab, graf
Article in English | LILACS | ID: lil-728806

ABSTRACT

After the World Health Organization officially declared the end of the first pandemic of the XXI century in August 2010, the influenza A(H1N1)pdm09 virus has been disseminated in the human population. In spite of its sustained circulation, very little on phylogenetic data or oseltamivir (OST) resistance is available for the virus in equatorial regions of South America. In order to shed more light on this topic, we analysed the haemagglutinin (HA) and neuraminidase (NA) genes of influenza A(H1N1)pdm09 positive samples collected during the pandemic period in the Pernambuco (PE), a northeastern Brazilian state. Complete HA sequences were compared and amino acid changes were related to clinical outcome. In addition, the H275Y substitution in NA, associated with OST resistance, was investigated by pyrosequencing. Samples from PE were grouped in phylogenetic clades 6 and 7, being clustered together with sequences from South and Southeast Brazil. The D222N/G HA gene mutation, associated with severity, was found in one deceased patient that was pregnant. Additionally, the HA mutation K308E, which appeared in Brazil in 2010 and was only detected worldwide the following year, was identified in samples from hospitalised cases. The resistance marker H275Y was not identified in samples tested. However, broader studies are needed to establish the real frequency of resistance in this Brazilian region.


Subject(s)
Female , Humans , Pregnancy , Hemagglutinins/genetics , Influenza A Virus, H1N1 Subtype/genetics , Influenza, Human/epidemiology , Neuraminidase/genetics , Pandemics , Antiviral Agents/therapeutic use , Biomarkers/analysis , Brazil/epidemiology , Drug Resistance, Viral/physiology , Gene Frequency/genetics , Influenza A Virus, H1N1 Subtype/classification , Influenza A Virus, H1N1 Subtype/pathogenicity , Influenza, Human/virology , Mutation/genetics , Oseltamivir/therapeutic use , Phylogeny , RNA, Viral/analysis , Sequence Analysis, DNA/methods , Virulence , Virulence Factors/genetics
14.
An Bras Dermatol ; 89(3): 478-80, 2014.
Article in English | MEDLINE | ID: mdl-24937823

ABSTRACT

A case of abscess resulting from Mycobacterium kansasii, in the left thigh of a 53-year-old woman infected with the Human Immunodeficiency virus, is reported. Curiously, there was no pulmonary or systemic involvement as is usual with these Mycobacterium infections. The patient had CD4 T lymphocyte count of 257 cells/µL and a viral load of 60,154 copies. Despite presenting a relatively preserved immunity, the patient also presented Criptococcic meningoencephalitis and Esophageal candidiasis. The patient responded satisfactorily to treatment for infections and after 51 days was discharged.


Subject(s)
AIDS-Related Opportunistic Infections/complications , Abscess/microbiology , Mycobacterium Infections, Nontuberculous/complications , Mycobacterium kansasii , AIDS-Related Opportunistic Infections/drug therapy , Abscess/diagnosis , Abscess/drug therapy , Female , Humans , Magnetic Resonance Imaging , Middle Aged , Mycobacterium Infections, Nontuberculous/drug therapy , Thigh , Treatment Outcome
15.
An. bras. dermatol ; 89(3): 478-480, May-Jun/2014. graf
Article in English | LILACS | ID: lil-711600

ABSTRACT

A case of abscess resulting from Mycobacterium kansasii, in the left thigh of a 53-year-old woman infected with the Human Immunodeficiency virus, is reported. Curiously, there was no pulmonary or systemic involvement as is usual with these Mycobacterium infections. The patient had CD4 T lymphocyte count of 257 cells/µL and a viral load of 60,154 copies. Despite presenting a relatively preserved immunity, the patient also presented Criptococcic meningoencephalitis and Esophageal candidiasis. The patient responded satisfactorily to treatment for infections and after 51 days was discharged.


Subject(s)
Female , Humans , Middle Aged , AIDS-Related Opportunistic Infections/complications , Abscess/microbiology , Mycobacterium kansasii , Mycobacterium Infections, Nontuberculous/complications , AIDS-Related Opportunistic Infections/drug therapy , Abscess/diagnosis , Abscess/drug therapy , Magnetic Resonance Imaging , Mycobacterium Infections, Nontuberculous/drug therapy , Thigh , Treatment Outcome
16.
Rev. Inst. Med. Trop. Säo Paulo ; 56(2): 139-142, Mar-Apr/2014. tab
Article in English | LILACS | ID: lil-703738

ABSTRACT

Objective: To assess quantitative real-time polymerase chain reaction (q-PCR) for the sputum smear diagnosis of pulmonary tuberculosis (PTB) in patients living with HIV/AIDS with a clinical suspicion of PTB. Method: This is a prospective study to assess the accuracy of a diagnostic test, conducted on 140 sputum specimens from 140 patients living with HIV/AIDS with a clinical suspicion of PTB, attended at two referral hospitals for people living with HIV/AIDS in the city of Recife, Pernambuco, Brazil. A Löwenstein-Jensen medium culture and 7H9 broth were used as gold standard. Results: Of the 140 sputum samples, 47 (33.6%) were positive with the gold standard. q-PCR was positive in 42 (30%) of the 140 patients. Only one (0.71%) did not correspond to the culture. The sensitivity, specificity and accuracy of the q-PCR were 87.2%, 98.9% and 95% respectively. In 39 (93%) of the 42 q-PCR positive cases, the CT (threshold cycle) was equal to or less than 37. Conclusion: q-PCR performed on sputum smears from patients living with HIV/AIDS demonstrated satisfactory sensitivity, specificity and accuracy, and may therefore be recommended as a method for diagnosing PTB.


Objetivo: Evaluar la Reacción en Cadena de Polimerasa en tiempo real cuantitativa (qPCR) para el diagnóstico de tuberculosis pulmonar (TBP) en esputo de pacientes con sida y sospecha clínica de TBP. Método: Se trata de un estudio prospectivo para evaluación de precisión de prueba diagnóstica, realizado en 140 muestras de esputo provenientes de 140 pacientes con sida y sospecha clínica de TBP atendidos en dos hospitales de referencia para atención VIH/sida en Recife-PE, Brasil. Se utilizó el cultivo en medios Löwenstein-Jensen y 7H9 como estándar de oro. Resultados: De las 140 muestras de esputo, 47 (33,6%) fueron positivas por el estándar de oro. La qPCR fue positiva en 42 (30%) de los pacientes. En apenas un (0.71%) caso no correspondió con el cultivo. La sensibilidad, especificidad y precisión de la qPCR fueron 87,2%, 98,9% y 95% respectivamente. De las 42 qPCR positivas en 39 (93%) el CT (threshold cycle) fue igual o inferior a 37. Conclusión: La qPCR realizada en muestra de esputo de pacientes con sida demostró sensibilidad, especificidad y precisión satisfactoria, pudiendo ser recomendada como método de diagnóstico de TBP.


Subject(s)
Adult , Female , Humans , Male , Middle Aged , Young Adult , AIDS-Related Opportunistic Infections/diagnosis , DNA, Bacterial/analysis , Mycobacterium tuberculosis/genetics , Real-Time Polymerase Chain Reaction , Sputum/microbiology , Tuberculosis, Pulmonary/diagnosis , Mycobacterium tuberculosis/isolation & purification , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity
17.
Rev Inst Med Trop Sao Paulo ; 56(2): 139-42, 2014.
Article in English | MEDLINE | ID: mdl-24626416

ABSTRACT

OBJECTIVE: To assess quantitative real-time polymerase chain reaction (q-PCR) for the sputum smear diagnosis of pulmonary tuberculosis (PTB) in patients living with HIV/AIDS with a clinical suspicion of PTB. METHOD: This is a prospective study to assess the accuracy of a diagnostic test, conducted on 140 sputum specimens from 140 patients living with HIV/AIDS with a clinical suspicion of PTB, attended at two referral hospitals for people living with HIV/AIDS in the city of Recife, Pernambuco, Brazil. A Löwenstein-Jensen medium culture and 7H9 broth were used as gold standard. RESULTS: Of the 140 sputum samples, 47 (33.6%) were positive with the gold standard. q-PCR was positive in 42 (30%) of the 140 patients. Only one (0.71%) did not correspond to the culture. The sensitivity, specificity and accuracy of the q-PCR were 87.2%, 98.9% and 95% respectively. In 39 (93%) of the 42 q-PCR positive cases, the CT (threshold cycle) was equal to or less than 37. CONCLUSION: q-PCR performed on sputum smears from patients living with HIV/AIDS demonstrated satisfactory sensitivity, specificity and accuracy, and may therefore be recommended as a method for diagnosing PTB.


Subject(s)
AIDS-Related Opportunistic Infections/diagnosis , DNA, Bacterial/analysis , Mycobacterium tuberculosis/genetics , Real-Time Polymerase Chain Reaction , Sputum/microbiology , Tuberculosis, Pulmonary/diagnosis , Adult , Female , Humans , Male , Middle Aged , Mycobacterium tuberculosis/isolation & purification , Predictive Value of Tests , Prospective Studies , Sensitivity and Specificity , Young Adult
18.
Int J STD AIDS ; 24(12): 951-6, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23970596

ABSTRACT

The study describes the main chest radiographic changes in people living with HIV/AIDS and pulmonary tuberculosis, confirmed by sputum culture. This was a descriptive study involving a total of 42 sputum tests from 42 people living with HIV/AIDS and a clinical suspicion of pulmonary tuberculosis. All patients attended two referral hospitals in Recife-PE, Brazil, between August 2009 and January 2012. The most common isolated radiological change was parenchymal consolidation, encountered in six (14.3%) patients, followed by patterns of interstitial infiltrate, diffuse micronodular (miliary), and an association between interstitial infiltrate and parenchymal consolidation, each being encountered in five (11.9%) patients. No statistically significant difference was observed between the radiological findings and CD4 T-cell counts, p = 0.680.


Subject(s)
AIDS-Related Opportunistic Infections/diagnostic imaging , HIV Infections/complications , Mycobacterium tuberculosis/isolation & purification , Sputum/microbiology , Tuberculosis, Pulmonary/diagnostic imaging , AIDS-Related Opportunistic Infections/complications , Adult , Brazil , CD4 Lymphocyte Count , Enzyme-Linked Immunosorbent Assay , Female , HIV Infections/diagnosis , Humans , Lung/diagnostic imaging , Male , Middle Aged , Prospective Studies , Radiography , Tuberculosis, Pulmonary/complications
19.
Rev Bras Hematol Hemoter ; 35(1): 39-43, 2013.
Article in English | MEDLINE | ID: mdl-23580883

ABSTRACT

OBJECTIVE: To determine the prevalence of hyperglycemia during induction therapy in adult patients with acute leukemia and its effect on complicated infections and mortality during the first 30 days of treatment. METHODS: An analysis was performed in a retrospective cohort of 280 adult patients aged 18 to 60 years with previously untreated acute leukemia who received induction chemotherapy from January 2000 to December 2009 at the Hemocentro de Pernambuco (HEMOPE), Brazil. Hyperglycemia was defined as the finding of at least one fasting glucose measurement > 100 mg/dL observed one week prior to induction therapy until 30 days after. The association between hyperglycemia and complicated infections, mortality and complete remission was evaluated using the Chi-square or Fisher's exact tests by the Statistical Package for Social Sciences (SPSS) in the R software package version 2.9.0. RESULTS: One hundred and eighty-eight patients (67.1%) presented hyperglycemia at some moment during induction therapy. Eighty-two patients (29.3%) developed complicated infections. Infection-related mortality during the neutropenia period was 20.7% (58 patients). Mortality from other causes during the first 30 days after induction was 2.8%. Hyperglycemia increased the risk of complicated infections (OR 3.97; 95% confidence interval: 2.08 - 7.57; p-value < 0.001) and death (OR 3.55; 95% confidence interval: 1.77-7.12; p-value < 0.001) but did not increase the risk of fungal infections or decrease the probability of achieving complete remission. CONCLUSION: This study demonstrates an association between the presence of hyperglycemia and the development of complicated infections and death in adult patients during induction therapy for acute leukemia.

20.
Arch Gynecol Obstet ; 288(3): 643-8, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23529684

ABSTRACT

OBJECTIVE: To assess the detection of Human Papillomavirus (HPV) in cervical biopsies, and its association with clinical response and survival of patients with cervical cancer. METHOD: The presence of HPV was determined by polymerase chain reaction (nested PCR) of material from 183 paraffin blocks containing biopsies of patients with cervical cancer. Directives of the International Federation of Gynecology and Obstetrics (FIGO) were used for the clinical staging of all cases. Survival analysis was conducted with the Kaplan-Meier method and differences between the curves were calculated by the log-rank test. RESULTS: Amplification was positive in 78 cases, negative in 96 cases and indeterminate in 9. The detection of HPV had no statistically significant effect on the survival of patients. CONCLUSIONS: From amongst the variables analyzed, only HPV positivity and clinical staging influenced a complete response after completing treatment. However, clinical staging was the only factor associated with progression of the disease, with patients in the early stages presenting better overall survival rates (p < 0.001).


Subject(s)
Carcinoma, Squamous Cell/virology , Papillomaviridae/isolation & purification , Uterine Cervical Neoplasms/virology , Brazil/epidemiology , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/mortality , Female , Humans , Middle Aged , Neoplasm Staging , Prognosis , Uterine Cervical Neoplasms/diagnosis , Uterine Cervical Neoplasms/mortality
SELECTION OF CITATIONS
SEARCH DETAIL
...